These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 3349229)
21. Modulation of neurotransmitter action: control of the gamma-aminobutyric acid response through the benzodiazepine receptor. Chan CY; Farb DH J Neurosci; 1985 Sep; 5(9):2365-73. PubMed ID: 2863335 [TBL] [Abstract][Full Text] [Related]
22. On the convulsant action of Ro 5-4864 and the existence of a micromolar benzodiazepine binding site in rat brain. File SE; Green AR; Nutt DJ; Vincent ND Psychopharmacology (Berl); 1984; 82(3):199-202. PubMed ID: 6326177 [TBL] [Abstract][Full Text] [Related]
23. Pro- and anti-convulsant properties of PK 11195, a ligand for benzodiazepine binding sites: development of tolerance. File SE Br J Pharmacol; 1984 Oct; 83(2):471-6. PubMed ID: 6091832 [TBL] [Abstract][Full Text] [Related]
24. Coincidence of seizure susceptibility to caffeine and to the benzodiazepine inverse agonist, DMCM, in SWR and CBA inbred mice. Seale TW; Carney JM; Rennert OM; Flux M; Skolnick P Pharmacol Biochem Behav; 1987 Feb; 26(2):381-7. PubMed ID: 3575358 [TBL] [Abstract][Full Text] [Related]
25. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. II. Chronic effects of ethanol. Buck KJ; Harris RA J Pharmacol Exp Ther; 1990 May; 253(2):713-9. PubMed ID: 2160008 [TBL] [Abstract][Full Text] [Related]
26. Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation. Leppä E; Linden AM; Rabe H; Vekovischeva OY; Wulff P; Lüddens H; Wisden W; Korpi ER Eur J Pharmacol; 2011 Sep; 666(1-3):111-21. PubMed ID: 21616065 [TBL] [Abstract][Full Text] [Related]
27. Benzodiazepine inverse agonist, DMCM- and peripheral agonist, Ro 5-4864-induced convulsions in mice: effect of adenosinergic agents. Thorat SN; Kulkarni SK Indian J Exp Biol; 1990 Dec; 28(12):1160-5. PubMed ID: 2099332 [TBL] [Abstract][Full Text] [Related]
28. Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice. De Sarro G; Ibbadu GF; Marra R; Rotiroti D; Loiacono A; Donato Di Paola E; Russo E Neurosci Res; 2004 Sep; 50(1):37-44. PubMed ID: 15288497 [TBL] [Abstract][Full Text] [Related]
29. beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site. Stevenson A; Wingrove PB; Whiting PJ; Wafford KA Mol Pharmacol; 1995 Dec; 48(6):965-9. PubMed ID: 8848011 [TBL] [Abstract][Full Text] [Related]
30. Convulsant effect of Ro 5-4864, a peripheral type benzodiazepine, on the baboon (Papio papio). Valin A; Bryere P; Naquet R Neurosci Lett; 1986 May; 66(2):210-4. PubMed ID: 3014388 [TBL] [Abstract][Full Text] [Related]
31. Bidirectional effects of benzodiazepine receptor ligands against picrotoxin- and pentylenetetrazol-induced seizures. Jensen LH; Petersen EN J Neural Transm; 1983; 58(3-4):183-91. PubMed ID: 6319592 [TBL] [Abstract][Full Text] [Related]
32. Modulation of gamma-aminobutyric acidA receptor-operated chloride channels by benzodiazepine inverse agonists is related to genetic differences in ethanol withdrawal seizure severity. Buck KJ; McQuilkin SJ; Harris RA J Neurochem; 1991 Dec; 57(6):2100-5. PubMed ID: 1658234 [TBL] [Abstract][Full Text] [Related]
33. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents. Chapman AG; Cheetham SC; Hart GP; Meldrum BS; Westerberg E J Neurochem; 1985 Aug; 45(2):370-81. PubMed ID: 2861248 [TBL] [Abstract][Full Text] [Related]
34. Reduction of gamma-aminobutyric acid (GABA)-mediated transmission by a convulsant benzodiazepine. Schlosser W; Franco S J Pharmacol Exp Ther; 1979 Nov; 211(2):290-5. PubMed ID: 501563 [TBL] [Abstract][Full Text] [Related]
35. Blockade of 3-carbomethoxy-beta-carboline induced seizures by diazepam and the benzodiazepine antagonists, Ro 15-1788 and CGS 8216. Schweri M; Cain M; Cook J; Paul S; Skolnick P Pharmacol Biochem Behav; 1982 Sep; 17(3):457-60. PubMed ID: 6815667 [TBL] [Abstract][Full Text] [Related]
36. Benzodiazepine-receptor mediated convulsions in infant rats: effects of beta-carbolines. Nutt DJ; Little H Pharmacol Biochem Behav; 1986 Apr; 24(4):841-4. PubMed ID: 3012598 [TBL] [Abstract][Full Text] [Related]
37. Acute and chronic effects of the benzodiazepine receptor ligand FG 7142: proconvulsant properties and kindling. Little HJ; Nutt DJ; Taylor SC Br J Pharmacol; 1984 Dec; 83(4):951-8. PubMed ID: 6097329 [TBL] [Abstract][Full Text] [Related]
38. Characteristics of an atypical benzodiazepine, Ro 5-4864. Pellow S; File SE Neurosci Biobehav Rev; 1984; 8(3):405-13. PubMed ID: 6095153 [TBL] [Abstract][Full Text] [Related]
39. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate. Yang XM; Luo ZP; Zhou JH J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863 [TBL] [Abstract][Full Text] [Related]
40. Mice and rats are sensitized to the proconvulsant action of a benzodiazepine-receptor inverse agonist (FG 7142) following a single dose of lorazepam. Lister RG; Nutt DJ Brain Res; 1986 Aug; 379(2):364-6. PubMed ID: 3017512 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]